Last updated on October 2007

Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2

Brief description of study

The response to vaccination for hepatitis is reduced in patients with HIV infection. The hypothesis of the study is that adjuvant interleukin-2 administered subcutaneously at the time of vaccination improves the response rate.

Clinical Study Identifier: NCT00451984

Find a site near you

Start Over